Raleigh pharma earns FDA approval for low testosterone drug

A Raleigh drugmaker developing therapies for testosterone deficiency has secured its first approval from the FDA. Next up, international markets.

Source: bizjournals.com Health Care:Physician Practices headlines - August 2, 2022 Category: American Health Authors: Zac Ezzone Source Type: news